Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2015 | 1 |
2018 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study.
J Heart Lung Transplant. 2019 Jan;38(1):43-50. doi: 10.1016/j.healun.2018.09.003. Epub 2018 Sep 12.
J Heart Lung Transplant. 2019.
PMID: 30391194
Free article.
Clinical Trial.
Long-term therapy with oral treprostinil in pulmonary arterial hypertension failed to lead to improvement in important physiologic measures: results from a single center.
Chin KM, Ruggiero R, Bartolome S, Velez-Martinez M, Darsaklis K, Kingman M, Harden S, Torres F.
Chin KM, et al.
Pulm Circ. 2015 Sep;5(3):513-20. doi: 10.1086/682224.
Pulm Circ. 2015.
PMID: 26401252
Free PMC article.
Item in Clipboard
Does treatment response to ambrisentan vary by pulmonary arterial hypertension severity? Implications for clinicians and for the design of future clinical trials.
Chin KM, Bartolome S, Miller K, Blair C, Gillies H, Torres F.
Chin KM, et al.
Int J Clin Pract. 2014 May;68(5):568-77. doi: 10.1111/ijcp.12331. Epub 2014 Feb 6.
Int J Clin Pract. 2014.
PMID: 24499136
Free PMC article.
Item in Clipboard
Cite
Cite